Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
The following substances in this Batch have been included in the Aromatic Azo and Benzidine-based Substance Grouping under Substance Groupings Initiative as part of the second phase of the Chemicals Management Plan. As outlined in the Notice of intent for the Aromatic Azo and Benzidine-based Substance Grouping, it was recognized that assessments and conclusions pertaining to some of the substances in the grouping may be subsequently updated as part of the subgroup assessment. The latest updates on these substances are found on the respective Substance Groupings Initiative pages.
|CAS RN||Chemical Substances||Substance Groupings Initiative|
|7147-42-4||BPAOPB||Certain Diarylide Yellow Pigments|
|6358-57-2||Acid Red 111||Certain Benzidine-based Dyes and Related Substances|
|1937-37-7||Direct Black 38|
|Solvent Red 23
Solvent Red 1
|Certain Azo Solvent Dyes|
|3118-97-6||Solvent Orange 7|
|6535-42-8||Solvent Red 3|
|6250-23-3||Disperse Yellow 23||Certain Azo Disperse Dyes|
|6253-10-7||Disperse Orange 13|
|6300-37-4||Disperse Yellow 7|
|19800-42-1||Disperse Orange 29|
|21811-64-3||Disperse Yellow 68|
The Risk Management Action Milestones table outlines the risk management actions that were proposed for the chemical substance in this batch of the Challenge that met the criteria of section 64 of the Canadian Environmental Protection Act, 1999 (CEPA 1999). These proposed risk management actions were published in the risk management approach document for this substance. For the complete wording of these proposed actions, please refer to the risk management approach document.
Two substances in this batch have been included in final Orders to add to Schedule 1.
Three Orders have been published addressing twelve substances in this batch through the application of Significant New Activity (SNAc) provisions.
In January 2017, a Notice of intent to amend the Domestic Substances List (DSL) to vary the SNAc requirements for benzyl chloride (CAS RN 100-44-7) was published in the Canada Gazette, Part I. The proposed amendment is an outcome of the SNAc Review. The DSL amendment is not in force until the final Order is adopted by the Minister of the Environment pursuant to subsection 87(3) of CEPA 1999. The final Order will be published in the Canada Gazette, Part II. Any current SNAc requirements remain in effect until such time as the final Order is published.
For additional guidance on submitting information required as part of SNAc notifications, please see the Guidelines for the Notification and Testing of New Substances: Chemicals and Polymers.
In October 2016, the SNAc provisions on Solvent Red 3 (CAS RN 6535-42-8) were rescinded. Solvent Red 3 was subject to the SNAc provisions as a result of the 2010 assessment of Batch 6 of the Challenge. Solvent Red 3 has since been included in the Certain Azo Solvent Dyes subgroup, and the 2016 assessment of that subgroup concluded that Solvent Red 3 does not pose a risk to the environment or human health. An Order was published in the Canada Gazette, Part II: Vol. 150, No. 21 - October 19, 2016 (PDF Version - 1,622 K) rescinding the obligations under the SNAc provisions of CEPA 1999 concerning this substance.
One substance in this batch has been assessed for new activities notified through a Significant New Activity Notification (SNAN). One Significant New Activity Notification Risk Assessment Summary has been published.
|CAS RN||Chemical Substance||Final Order and RIAS||Public Comments on the Proposed Risk Management Approach||Final Screening Assessment||Proposed Risk Management Approach||Public Comments on the Draft Screening Assessment and Risk Management Scope|
|85-86-9||Solvent Red 23||HTML||None||None|
|CAS RN||Chemical Substance||Final Screening Assessment||Public Comments|
|1229-55-6||Solvent Red 1|
|1937-37-7||Direct Black 38||None|
|3118-97-6||Solvent Orange 7|
|6250-23-3||Disperse Yellow 23||None|
|6253-10-7||Disperse Orange 13||None|
|6300-37-4||Disperse Yellow 7||None|
|6358-57-2||Acid Red 111||None|
|19800-42-1||Disperse Orange 29||None|
|21811-64-3||Disperse Yellow 68||None|
|6535-42-8||Solvent Red 3|
|January 14, 2017||CAS RN 100-44-7||Publication in the Canada Gazette of a Notice of intent to amend the DSL to vary the SNAc requirements, and start of 60-day public comment period.|
|December 14, 2016||CAS RN 85-86-9||Publication in Canada Gazette of final Order adding one substance to Schedule 1.|
|October 19, 2016||CAS RN 6535-42-8||Publication in Canada Gazette of final Order rescinding the SNAc provisions of CEPA 1999.|
|September 9, 2016||CAS RN 100-44-7||Publication of a SNAN risk assessment summary.|
|May 8, 2013||CAS RN 100-44-7||Publication in Canada Gazette of Order amending the DSL to apply the SNAc provisions of CEPA 1999.|
|December 21, 2011||CAS RN 100-44-7||Publication in Canada Gazette of final Order adding one substance to Schedule 1.|
|November 26, 2011||CAS RN 100-44-7||Publication in Canada Gazette of Notice of intent to amend the DSL to apply the SNAc provisions of CEPA 1999, and start of 60-day public comment period.|
|October 15, 2011||CAS RN 85-86-9||Publication in Canada Gazette of proposed Order adding substance to Schedule 1, and start of 60-day public comment period.|
|September 10, 2011||CAS RNs 85-86-9, 19800-42-1, 6358-57-2 and 7147-42-4||Publication in Canada Gazette of final assessment decision under subsection 77(6).|
|November 10, 2010||CAS RNs 107-05-1, 117-82-8, 1937-37-7, 6250-23-3, 6253-10-7, 6300-37-4, 21811-64-3, 93805-00-6, 1229-55-6, 3118-97-6 and 6535-42-8||Publication in Canada Gazette of two Orders amending the DSL to apply the SNAc provisions of CEPA 1999.|
|October 2, 2010||CAS RNs 85-86-9, 6358-57-2, 7147-42-4 and 19800-42-1||Publication in Canada Gazette and start of 60-day public comment period on (a) the draft screening assessments, (b) the proposals to pursue one of the measures as specified under subsection 77(2) and (c) the risk management scope documents.|
|March 6, 2010||CAS RNs 1229-55-6, 3118-97-6, 6250-23-3, 6253-10-7, 6300-37-4, 6535-42-8, 21811-64-3 and 93805-00-6||Publication in Canada Gazette of Notice of intent to amend the DSL to apply the SNAc provisions of CEPA 1999, and start of 60-day public comment period.|
|February 27, 2010||CAS RNs 100-44-7||Publication in Canada Gazette of proposed Order adding a substance to Schedule 1, and start of 60-day public comment period.|
|November 28, 2009||14 of the 18 substances in Batch 6||Publication in Canada Gazette of final assessment decision under subsection 77(6), release of proposed risk management approach documents, and start of 60-day public comment period on the proposed risk management approach documents.|
|November 28, 2009||CAS RNs 107-05-1, 117-82-8 and 1937-37-7||Publication in Canada Gazette of Notice of intent to amend the DSL to apply the SNAc provisions of CEPA 1999, and start of 60-day public comment period.|
|May 30, 2009||All Batch 6 substances||Publication in Canada Gazette and start of 60-day public comment period on (a) the draft screening assessments, (b) the proposals to pursue one of the measures as specified under subsection 77(2) and (c) the risk management scope documents.|
|November 27, 2008||All Batch 6 substances||Deadline for submission of additional information by interested stakeholders, including on the extent and nature of the management/stewardship of Batch 6 substances.|
|September 30, 2008||All Batch 6 substances||Deadline for submission of information under the section 71 Notice on Batch 6 substances (if no extension granted).|
|May 31, 2008||All Batch 6 substances||Release of Batch 6 of the Challenge and the accompanying technical documents.|
In September 2011, the final screening assessments for the remaining four substances in this batch were released in the Canada Gazette, Part I: Vol. 145, No. 37 - September 10, 2011 (PDF Version - 1,147 K).
In November 2009, the final screening assessments for 14 of the 18 substances in this batch were released in the Canada Gazette, Part I: Vol. 143, No. 48 - November 29, 2009 (PDF Version - 714 K).
The final screening assessments concluded that two substances in this batch meet one or more criteria in section 64 of the CEPA 1999. The Government proposed to add these substances to Schedule 1 of the Act. Proposed risk management approach documents were also released for the substances in this batch which met the criteria in section 64 of CEPA 1999.
New information was received from industry or interested stakeholders for each of the 18 substances in this batch. In May 2009, the draft screening assessments were released and the related Notices were published in the Canada Gazette, Part I: Vol. 143, No. 22 - May 30, 2009 (PDF Version - 818 K). Risk management scope documents were also released in conjunction with these publications.
In October 2010, a Notice relating to the release of the draft screening assessments for the four remaining substances in Batch 6 (CAS RNs 85-86-9, 6358-57-2, 7147-42-4 and 19800-42-1), was published in the Canada Gazette, Part I: Vol. 144, No. 40 - October 2, 2010 (PDF Version - 1,571 K).
New content has been added regarding the human health aspects of the assessments and has led to the re-publication of the draft screening assessments on these substances in order to allow a public comment period on the updated content. Risk management scope documents were also released in conjunction with these publications.
Information on substances in this batch was gathered from industry and interested stakeholders through a mandatory survey Notice issued under section 71 of CEPA 1999. They were also invited to complete a voluntary questionnaire.
A Notice related to the launch of Batch 6 was published in May 2008 in the Canada Gazette. The section 71 Notice applied to all 18 substances in this batch.
|Approximate Number||Type of Response|
|60||Responses to mandatory section 71 Notice (responses were received relating to 13 substances in the batch)|
|15||Requests for extension of the deadline for section 71 Notice responses granted|
|10||Voluntary submissions of Questionnaires (Questionnaires were received relating to six substances in the batch)|
|90||Expressions of "Stakeholder Interest" (responses were received relating to all substances in the batch)|
|25||Other submissions (for example, studies, additional information)
(submissions were received relating to nine substances in the batch)